Anticorps Recombinant de lapin anti-LASS2

LASS2 Recombinant Antibody for WB, IHC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IHC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

241898E11

N° de cat : 84514-4-PBS

Synonymes

241898E11, Ceramide synthase 2, CerS2, EC:2.3.1.24, EC:2.3.1.297



Informations sur le produit

84514-4-PBS cible LASS2 dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène LASS2 Protéine recombinante Ag14151
Nom complet LAG1 homolog, ceramide synthase 2
Masse moléculaire calculée 380 aa, 45 kDa
Poids moléculaire observé40 kDa
Numéro d’acquisition GenBankBC010032
Symbole du gène LASS2
Identification du gène (NCBI) 29956
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

LASS2, also known as TMSG1, is a novel suppressor of human cancer metastasis. As one member of LASS family, including LASS1-6, LASS2 mRNA is at the highest level of all LASS members, and has the broadest tissue distribution, particularly abundant in the liver, kidney and brain in mice. The biological roles of LASS2 include protection from aging , hepatic INS resistance, and hepatocellular carcinoma (HCC) progression. LASS2 has been correlated with the degree of invasion and recurrence of carcinomas of the prostate, liver, breast and bladder.

{{ptg:RelatedPrimaryAntibodies}}